| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 06/16/2009 | US7547769 Immunomodulatory constructs and their uses |
| 06/16/2009 | CA2282727C Cell surface molecule mediating cell adhesion and signal transmission |
| 06/16/2009 | CA2158322C Immunoconjugate comprising an anti-egf receptor antibody and interleukin-8 |
| 06/11/2009 | WO2009073808A2 Compositions and methods to modulate cell membrane resealing |
| 06/11/2009 | WO2009072609A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 06/11/2009 | WO2009072608A1 Gene capable of increasing the production of oil-and-fat in plant, and use thereof |
| 06/11/2009 | WO2001098458A3 Methods for immobilizing polypeptides |
| 06/11/2009 | US20090149635 Antibodies to human zcytor17 ligand |
| 06/11/2009 | US20090148940 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148939 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148925 Single chain class I major histocompatibility complexes |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148471 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 06/11/2009 | US20090148465 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 06/11/2009 | US20090148457 Hepatocyte growth factor receptor antagonists and uses thereof |
| 06/11/2009 | CA2853475A1 Genes that increase plant oil and method for using the same |
| 06/11/2009 | CA2708322A1 Genes that increase plant oil and method for using the same |
| 06/11/2009 | CA2708321A1 Genes that increase plant oil and method for using the same |
| 06/10/2009 | EP2067790A2 Agonist antibody against protein tyrosine kinase SAL-S1 |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067472A1 Compositions and methods for the diagnosis and treatment of tumor |
| 06/10/2009 | EP2066697A2 Modified self-assembling peptides |
| 06/10/2009 | EP2066691A1 Use of natural, recombinant and synthetic resilins in cosmetics |
| 06/10/2009 | EP2066690A2 Membrane-anchored 2 microglobulin covalently linked to mhc class i peptide epitopes |
| 06/10/2009 | EP1352070B1 A fibrin/fibrinogen-binding conjugate |
| 06/10/2009 | CN100497389C Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 06/10/2009 | CN100497387C Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 06/10/2009 | CN100497379C Protein complex serving as vehicle for orally administerable medicaments |
| 06/09/2009 | US7544783 Active constituent in antiallergic medicine; block the IgE acceptor; specifically bind to a native IgG inhibitory receptor containing immunoreceptor tyrosine-based inhibitory motif, thereby inhibiting the IgE-driven mediator release from mast cells and basophils |
| 06/09/2009 | US7544781 Polypeptide and process for producing the same |
| 06/09/2009 | US7544776 Long wavelength engineered fluorescent proteins |
| 06/09/2009 | US7544519 Identifying modulators for prevention and treatment of infection, blood, metabolic, cell proliferative and respiratory system disorders |
| 06/09/2009 | US7544512 Transforming and fermenting gene products from cells comprising nucleotide sequences coding glucagon like polypeptides for use in stimulation and secretion of insulin; diabetes treatment; bioreactors |
| 06/09/2009 | US7544487 Fusion proteins containing recombinant cytotoxic RNAses |
| 06/09/2009 | US7544484 secretory or chimeric fusion protein is composed of Vargula luciferase and Yellow fluorescent protein, having an energy transfer property, energy-generating protein and an energy-receiving protein; fluorescent protein is excited with light emitted from the light-emitting enzyme; drug screening |
| 06/09/2009 | US7544361 A fusion monomer of fusion protein of an antigen derived from an envelope protein of Japanese encephalitis virus and an amino acid sequence of a mucous membrane-binding protein monomer; industrial scale; purification efficiency; recombinant mucosal vaccine; intestinal immunization by oral administration |
| 06/09/2009 | CA2269083C Novel fgf homologs |
| 06/04/2009 | WO2009070234A2 Complexation of fatty acid-conjugated molecules with albumin |
| 06/04/2009 | WO2009070088A1 Antimicrobial polypeptide |
| 06/04/2009 | WO2009068042A2 Novel peptides derived from ncam (fgls) |
| 06/04/2009 | WO2009067800A1 Antibodies against a cancer-associated epitope of variant nfkbib and uses thereof |
| 06/04/2009 | US20090143276 Trimeric IL-1Ra |
| 06/04/2009 | US20090142794 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 06/04/2009 | US20090142376 Chlamydia polypeptides and corresponding dna fragments and uses thereof |
| 06/04/2009 | US20090142266 Peptides derived from maurocalcine used as vectors for intracellular addressing of molecules of interest |
| 06/04/2009 | CA2706633A1 Novel cancer-associated antibody and antigen |
| 06/03/2009 | EP2065467A2 Anti-interferon-alpha antibodies |
| 06/03/2009 | EP2065052A2 Anti-IgE vaccines |
| 06/03/2009 | EP1407017B1 Human tumor necrosis factor receptor |
| 06/03/2009 | EP1012283B1 Mage-3 peptides presented by hla class ii molecules |
| 06/03/2009 | CN101445800A T1r taste receptors and genes encoding same |
| 06/03/2009 | CN101445560A Method for preparing fusion protein used for livestock and poultry |
| 06/03/2009 | CN101445559A Trimeric collagen scaffold antibodies and uses thereof |
| 06/03/2009 | CN100493617C Recombinant adeno-associated virus for prevention and cure of I-type diabetes and use thereof |
| 06/02/2009 | US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins |
| 06/02/2009 | US7541439 Thrombopoietin proteins with improved properties |
| 06/02/2009 | US7541435 Antagonists of cxcr3-binding cxc chemokines |
| 06/02/2009 | US7541334 Hybrid peptides modulate the immune response |
| 06/02/2009 | US7541180 comprising administering to a cells or tissues in vitro; hepatitis C virus (HCV) antigens; dna immunization |
| 06/02/2009 | US7541170 Binding; amplification of nucleotide sequences; fusion proteins |
| 06/02/2009 | US7541154 GASP1: a follistatin domain containing protein |
| 06/02/2009 | US7541040 Chimeric molecule for the treatment of th2-like cytokine mediated disorders |
| 06/02/2009 | US7541039 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 06/02/2009 | US7541034 Recombinant antibodies and immunoconjugates targeted to CD-22 bearing cells and tumors |
| 06/02/2009 | CA2249351C Novel method of diagnosing and treating gliomas |
| 05/30/2009 | CA2618374A1 Trimeric collagen scaffold antibodies |
| 05/28/2009 | WO2009065292A1 Fusion protein comprising tumor necrosis factor related apoptosis inducing ligand and integrin ligand and use thereof |
| 05/28/2009 | US20090137782 Recognize aberrant glycosylated form of the EGFR; evident upon aberrant post-translational modification; cancer |
| 05/28/2009 | US20090137461 Abuse-resistant amphetamine prodrugs |
| 05/28/2009 | US20090137033 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 05/28/2009 | US20090136970 Nogo receptor homologues and their use |
| 05/28/2009 | US20090136962 Diagnostic markers for cancer |
| 05/28/2009 | US20090136536 Recombinant Subunit Vaccine |
| 05/28/2009 | US20090136475 Immunokinases |
| 05/28/2009 | US20090136467 Apolipoprotein analogues |
| 05/28/2009 | US20090136444 molecule and chimeric molecules thereof |
| 05/28/2009 | CA2706201A1 Peptides with capacity to bind to scurfin and applications |
| 05/27/2009 | EP2062974A1 Method of producing fused protein |
| 05/27/2009 | EP1403365B1 Polypeptide unstabilizing protein in cells under aerobic conditions and dna encoding the same |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP0959899B1 LO-CD2a ANTIBODY AND USES THEREOF FOR INHIBITING T CELL ACTIVATION AND PROLIFERATION |
| 05/27/2009 | CN101440369A Expression method of deleted zonula occludens toxin gene of Vibrio cholerae and use |
| 05/27/2009 | CN100491399C Hybrid protein of p53 protein epitope and filobactivirus gene 8 protein and application thereof |
| 05/26/2009 | US7538207 Polyepitope carrier protein |
| 05/26/2009 | US7538195 Antibodies that bind to human insulin-like growth factor-I receptor; particularly, antibodies that inhibit the cellular functions of the IGF-I receptor; cancer treatment |
| 05/26/2009 | US7538182 conjugated by bridging molecules to proteins or polypeptides, reporter groups or cytotoxic agents; cancer |
| 05/26/2009 | US7538091 D-retro-inverso amino acid sequence transporter peptide conjugated to nucleic acid biological effector; translocation across the membrane of pancreatic B-cells |
| 05/26/2009 | US7537771 Produces an immune response which is protective against Bacillus anthracis |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2295936C Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 05/22/2009 | WO2009064777A2 Production of fc-fusion polypeptides in eukaryotic algae |
| 05/22/2009 | WO2009064255A1 N-terminal xa27 signal anchor and its use for localization of fusion proteins |
| 05/22/2009 | WO2009063970A1 Diagnosis and treatment of cancer using anti-gpr49 antibody |
| 05/22/2009 | WO2009063461A1 Methods of treating cancer using anti cd24 antibodies |
| 05/22/2009 | WO2009042186A3 Genomic editing in zebrafish using zinc finger nucleases |
| 05/22/2009 | CA2705542A1 Production of fc-fusion polypeptides in eukaryotic algae |
| 05/22/2009 | CA2705509A1 Diagnosis and treatment of cancer using anti-gpr49 antibody |
| 05/22/2009 | CA2705353A1 Methods of treating cancer using anti cd24 antibodies |
| 05/22/2009 | CA2705289A1 Production of cytotoxic antibody-toxin fusion in eukaryotic algae |
| 05/21/2009 | US20090131645 used to control the interaction of particular cell types with their external environment; for chronic pain; reduced side effects, long-lasting actions that do not require frequent injections or long-term catheterization; does not lead to tolerance and associated dependence |